TONIX PHARMACEUTICALS HOLDING CORP. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2014-03-31 was $0.00.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2013-09-30 was $0.00.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, conversion of convertible securities for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, conversion of convertible securities for fiscal 2012 was $2.63M.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, conversion of convertible securities for fiscal 2011 was $0.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-13 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 10-K · filed 2014-03-28 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $710.00K derived: sum of 4 quarters · filed 2014-05-13 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $710.00K derived: sum of 4 quarters · filed 2014-05-13 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-13 | $2.63M derived: sum of 4 quarters · filed 2014-05-13 |
| 2012-12-31 | $710.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $2.63M 10-K · filed 2014-03-28 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $1.93M derived: sum of 4 quarters · filed 2013-11-22 |
| 2012-06-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $1.93M derived: sum of 4 quarters · filed 2013-11-22 |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-07 | |
| 2011-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-22 | $0.00 10-K/A · filed 2013-11-22 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |